These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38490043)

  • 21. A pilot study on the effect of oclacitinib on epicutaneous sensitization and transepidermal water loss in a colony of atopic beagle dogs.
    Marsella R; Ahrens K
    Vet Dermatol; 2018 Oct; 29(5):439-e146. PubMed ID: 29926994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of serum Interleukin 34 (IL-34) and correlation with severity and pruritus scores in client-owned dogs with atopic dermatitis.
    Gow DJ; Jackson H; Forsythe P; Nuttall T; Gow AG; Mellanby RJ; Hume DA
    Vet Dermatol; 2020 Oct; 31(5):359-e94. PubMed ID: 32794277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The frequency of urinary tract infection and subclinical bacteriuria in dogs with allergic dermatitis treated with oclacitinib: a prospective study.
    Simpson AC; Schissler JR; Rosychuk RAW; Moore AR
    Vet Dermatol; 2017 Oct; 28(5):485-e113. PubMed ID: 28513001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of a mixed cannabidiol and cannabidiolic acid based oil on client-owned dogs with atopic dermatitis.
    Loewinger M; Wakshlag JJ; Bowden D; Peters-Kennedy J; Rosenberg A
    Vet Dermatol; 2022 Aug; 33(4):329-e77. PubMed ID: 35644533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blind, placebo-controlled study to evaluate the effect of EFF1001, an Actinidia arguta (hardy kiwi) preparation, on CADESI score and pruritus in dogs with mild to moderate atopic dermatitis.
    Marsella R; Messinger L; Zabel S; Rosychuck R; Griffin C; Cronin PO; Belofsky G; Lindemann J; Stull D
    Vet Dermatol; 2010 Feb; 21(1):50-7. PubMed ID: 19843302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.
    Michels GM; Ramsey DS; Walsh KF; Martinon OM; Mahabir SP; Hoevers JD; Walters RR; Dunham SA
    Vet Dermatol; 2016 Dec; 27(6):478-e129. PubMed ID: 27647569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study.
    Hon KL; Leung TF; Ng PC; Lam MC; Kam WY; Wong KY; Lee KC; Sung YT; Cheng KF; Fok TF; Fung KP; Leung PC
    Br J Dermatol; 2007 Aug; 157(2):357-63. PubMed ID: 17501956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between clinical efficacy on pruritus and serum interleukin-31 levels in dogs with atopic dermatitis treated with lokivetmab.
    Calesso JR; Marques VS; de Carvalho OV; Costa-Val AP
    Pol J Vet Sci; 2023 Jun; 26(2):231-238. PubMed ID: 37389418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis.
    Visser M; Walsh K; King V; Sture G; Caneva L
    BMC Vet Res; 2022 Mar; 18(1):103. PubMed ID: 35300697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial.
    Nuttall T; Mueller R; Bensignor E; Verde M; Noli C; Schmidt V; Rème C
    Vet Dermatol; 2009 Jun; 20(3):191-8. PubMed ID: 19374721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-31-induced pruritus in dogs: a novel experimental model to evaluate anti-pruritic effects of canine therapeutics.
    Gonzales AJ; Fleck TJ; Humphrey WR; Galvan BA; Aleo MM; Mahabir SP; Tena JK; Greenwood KG; McCall RB
    Vet Dermatol; 2016 Feb; 27(1):34-e10. PubMed ID: 26666963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of oclacitinib treatment on antimicrobial usage in allergic dogs in primary practice: an Australia wide case-control study.
    Rynhoud H; Croton C; Henry G; Meler E; Gibson JS; Soares Magalhaes RJ
    BMC Vet Res; 2022 Apr; 18(1):151. PubMed ID: 35477466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of antipruritic and rehydrating foams on localized lesions of atopic dermatitis in dogs: a small-scale pilot and comparative double-blinded study.
    Bensignor EJ; Fabriès LJ
    Vet Dermatol; 2018 Oct; 29(5):446-e150. PubMed ID: 30079617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The glucocorticoid sparing efficacy of Phytopica in the management of canine atopic dermatitis.
    Schmidt V; McEwan N; Volk A; Helps J; Morrell K; Nuttall T
    Vet Dermatol; 2010 Feb; 21(1):96-105. PubMed ID: 20187915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomised, double-blinded trial to assess the effect of oclacitinib and prednisolone on intradermal allergen and prick tests in dogs with atopic dermatitis.
    Baretta LT; do Espírito Santo Cunha V; Figueiredo CD; Gerardi DG
    Vet Dermatol; 2024 Feb; 35(1):71-80. PubMed ID: 37770410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oclacitinib in feline nonflea-, nonfood-induced hypersensitivity dermatitis: results of a small prospective pilot study of client-owned cats.
    Ortalda C; Noli C; Colombo S; Borio S
    Vet Dermatol; 2015 Aug; 26(4):235-e52. PubMed ID: 25940959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid response of hyperkeratotic erythema multiforme to oclacitinib in two dogs.
    High EJ; Linder KE; Mamo LB; Levy BJ; Herrmann I; Bizikova P
    Vet Dermatol; 2020 Aug; 31(4):330-e86. PubMed ID: 32307815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral and subcutaneous therapy of canine atopic dermatitis with recombinant feline interferon omega.
    Litzlbauer P; Weber K; Mueller RS
    Cytokine; 2014 Mar; 66(1):54-9. PubMed ID: 24548425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ear tip ulcerative dermatitis treated with oclacitinib in 25 dogs: a retrospective case series.
    Colombo S; Cornegliani L; Vercelli A; Fondati A
    Vet Dermatol; 2021 Aug; 32(4):363-e100. PubMed ID: 34250688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hair cortisol concentration, disease severity and quality of life in dogs with atopic dermatitis during lokivetmab therapy.
    Stuart Marques V; Calesso JR; de Carvalho OV; da Costa-Val Bicalho AP
    Vet Dermatol; 2023 Aug; 34(4):339-347. PubMed ID: 37165693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.